It demonstrated that the agency no longer had a monopoly on the information needed to make drug and device safety decisions.

First and foremost, safety is a prime concern with a device that comes in contact with the eye.

Although we have our concerns as to the safety of that zoom in our pockets, there's no doubt that Sanyo has upped the ante for this type of device.